173 related articles for article (PubMed ID: 25266801)
1. Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer.
Mandal RK; Agrawal T; Mittal RD
Tumour Biol; 2015 Jan; 36(1):375-81. PubMed ID: 25266801
[TBL] [Abstract][Full Text] [Related]
2. Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.
Singh V; Srivastava P; Srivastava N; Kapoor R; Mittal RD
Mol Biol Rep; 2012 Oct; 39(10):9827-34. PubMed ID: 22733495
[TBL] [Abstract][Full Text] [Related]
3. Association of caspases with an increased prostate cancer risk in north Indian population.
Mittal RD; Mittal T; Singh AK; Mandal RK
DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection.
El-Bendary M; Neamatallah M; Elalfy H; Besheer T; El-Setouhy M; Youssef MM; Zein M; Elhammady D; Hegazy A; Esmat G
Br J Biomed Sci; 2019 Jan; 76(1):11-16. PubMed ID: 30175654
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
[TBL] [Abstract][Full Text] [Related]
6. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.
Pang Y; Li H; Gong Y; Jing S; Peng C; Liu W; Zhao Y; Wang H; Kaushik D; Rodriguez R; Wang Z
Oncol Rep; 2019 Apr; 41(4):2491-2501. PubMed ID: 30816510
[TBL] [Abstract][Full Text] [Related]
7. Functional genetic polymorphisms of monocyte chemoattractant protein 1 and C-C chemokine receptor type 2 in ischemic stroke.
Arakelyan A; Zakharyan R; Hambardzumyan M; Petrkova J; Olsson MC; Petrek M; Boyajyan A
J Interferon Cytokine Res; 2014 Feb; 34(2):100-5. PubMed ID: 24083412
[TBL] [Abstract][Full Text] [Related]
8. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
9. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
10. CCR2-64I is a risk factor for development of bladder cancer.
Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
[TBL] [Abstract][Full Text] [Related]
11. [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction].
Xu X; Wang LH; Liu HB; Xu CF; Zhang P; Yong F; Shi YP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):601-7. PubMed ID: 24078580
[TBL] [Abstract][Full Text] [Related]
12. The impact of MCP1-2518A/G and CCR2-V64I genetic polymorphisms in Egyptian sickle cell disease patients.
Ibrahim NS; Makhlouf MM; Shahin GH; Elghamrawy MK; Hussein NM
Exp Mol Pathol; 2022 Oct; 128():104834. PubMed ID: 36155203
[TBL] [Abstract][Full Text] [Related]
13. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.
Attar R; Agachan B; Kuran SB; Cacina C; Sozen S; Yurdum LM; Attar E; Isbir T
In Vivo; 2010; 24(2):243-8. PubMed ID: 20364004
[TBL] [Abstract][Full Text] [Related]
14. Death receptor 4 variants enhanced prostate cancer risk in North Indian population.
Mittal RD; Mandal RK; Singh A; Srivastava P
Tumour Biol; 2015 Jul; 36(7):5655-61. PubMed ID: 25691252
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of CCL2, CCL5, CCR2 and CCR5 genes in Sahariya tribe of North Central India: an association study with pulmonary tuberculosis.
Mishra G; Poojary SS; Raj P; Tiwari PK
Infect Genet Evol; 2012 Jul; 12(5):1120-7. PubMed ID: 22554651
[TBL] [Abstract][Full Text] [Related]
16. Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.
Viladés C; Broch M; Plana M; Domingo P; Alonso-Villaverde C; Pedrol E; Knobel H; Dalmau D; Peraire J; Gutiérrez C; López A; Sambeat MA; Olona M; Garcia F; Richart C; Gatell JM; Vidal F;
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):132-8. PubMed ID: 17091019
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
Mandal RK; Nissar K; Mittal RD
Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
[TBL] [Abstract][Full Text] [Related]
18. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.
Mandal RK; George GP; Mittal RD
Mol Biol Rep; 2012 Jul; 39(7):7263-9. PubMed ID: 22311043
[TBL] [Abstract][Full Text] [Related]
19. Combined association of CCR2-V64I and MCP-1-2518A/G polymorphisms with generalised aggressive periodontitis in Chinese.
Zhu XL; Meng HX; Xu L; Zhang L; Chen ZB; Shi D; Feng XH
Chin J Dent Res; 2010; 13(2):109-14. PubMed ID: 21264360
[TBL] [Abstract][Full Text] [Related]
20. Frequency of MCP-1 (rs1024611) and CCR2 (rs1799864) gene polymorphisms and its effect on gene expression level in patients with AgP.
Gunpinar S; Alptekin NO; Ucar VB; Acar H
Arch Oral Biol; 2017 Aug; 80():209-216. PubMed ID: 28458180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
